StockData
Labcorp Holdings Inc. logo

Labcorp Holdings Inc. (LH) stock

LHNYSEServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 11/3016% above fair value
$372.46+1.98 (+0.53%)

Close on Nov 16, 2026Market cap $30.24BP/E 30.6Yield 0.77%

Labcorp total assets

Total assets on the balance sheet at the end of each period.

Labcorp's total assets was $18.92B at Sep 30, 2026. For fiscal 2025 it was $18.39B, up 0.1% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is $20.39B in fiscal 2021.

Annual total assets

PeriodPeriod endValueChange
FY2025Dec 31, 2025$18.39B+0.1%
FY2024Dec 31, 2024$18.38B+9.9%
FY2023Dec 31, 2023$16.73B-17.0%
FY2022Dec 31, 2022$20.16B-1.1%
FY2021Dec 31, 2021$20.39B+1.6%
FY2020Dec 31, 2020$20.07B+11.2%
FY2019Dec 31, 2019$18.05B+11.5%
FY2018Dec 31, 2018$16.19B-2.9%
FY2017Dec 31, 2017$16.67B+17.0%
FY2016Dec 31, 2016$14.25B+1.0%
FY2015Dec 31, 2015$14.10B+93.2%
FY2014Dec 31, 2014$7.30B+4.8%
FY2013Dec 31, 2013$6.97B+2.5%
FY2012Dec 31, 2012$6.80B+11.2%
FY2011Dec 31, 2011$6.11B-1.2%
FY2010Dec 31, 2010$6.19B+27.9%
FY2009Dec 31, 2009$4.84B+3.6%
FY2008Dec 31, 2008$4.67B–

Quarterly total assets

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$18.92B+3.6%
Q2 FY2026Jun 30, 2026$18.53B+2.6%
Q1 FY2026Mar 31, 2026$19.09B+8.4%
Q4 FY2025Dec 31, 2025$18.39B+0.1%
Q3 FY2025Sep 30, 2025$18.26B-1.9%
Q2 FY2025Jun 30, 2025$18.06B+8.1%
Q1 FY2025Mar 31, 2025$17.60B+6.5%
Q4 FY2024Dec 31, 2024$18.38B+9.9%
Q3 FY2024Sep 30, 2024$18.61B+10.2%
Q2 FY2024Jun 30, 2024$16.71B-5.7%
Q1 FY2024Mar 31, 2024$16.53B-18.2%
Q4 FY2023Dec 31, 2023$16.73B-17.0%
Q3 FY2023Sep 30, 2023$16.89B-14.8%
Q2 FY2023Jun 30, 2023$17.72B-13.2%
Q1 FY2023Mar 31, 2023$20.20B-2.5%
Q4 FY2022Dec 31, 2022$20.16B-1.1%
Q3 FY2022Sep 30, 2022$19.83B-5.0%
Q2 FY2022Jun 30, 2022$20.40B-0.1%
Q1 FY2022Mar 31, 2022$20.73B+1.5%
Q4 FY2021Dec 31, 2021$20.39B+1.6%
Q3 FY2021Sep 30, 2021$20.87B+11.3%
Q2 FY2021Jun 30, 2021$20.42B+14.4%
Q1 FY2021Mar 31, 2021$20.42B+18.0%
Q4 FY2020Dec 31, 2020$20.07B+11.2%
Q3 FY2020Sep 30, 2020$18.74B+5.0%
Q2 FY2020Jun 30, 2020$17.85B+0.6%
Q1 FY2020Mar 31, 2020$17.30B+1.9%
Q4 FY2019Dec 31, 2019$18.05B+11.5%
Q3 FY2019Sep 30, 2019$17.85B+7.1%
Q2 FY2019Jun 30, 2019$17.74B+7.5%
Q1 FY2019Mar 31, 2019$16.97B+0.8%
Q4 FY2018Dec 31, 2018$16.19B-2.9%
Q3 FY2018Sep 30, 2018$16.66B-0.2%
Q2 FY2018Jun 30, 2018$16.50B+10.7%
Q1 FY2018Mar 31, 2018$16.83B+16.7%
Q4 FY2017Dec 31, 2017$16.67B+17.0%
Q3 FY2017Sep 30, 2017$16.69B–
Q2 FY2017Jun 30, 2017$14.90B–
Q1 FY2017Mar 31, 2017$14.43B–
Q4 FY2016Dec 31, 2016$14.25B–

More Labcorp figures

See a number that looks wrong?